Truist cuts Biomea Fusion to hold, cites clinical hold uncertainty

seekingalpha06-11

Truist Securities has lowered its rating on Biomea Fusion (NASDAQ:BMEA) to hold, citing uncertainty about the timeline for resolving an FDA clinical hold on the company’s lead asset BMF-219. “We ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2442031363?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1384646810/image_1384646810.jpg","is_english":true,"pubTime":"2024-06-11 22:52","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2442031363","market":"nz","top_or_hot":-1,"title":"Truist cuts Biomea Fusion to hold, cites clinical hold uncertainty","media":"seekingalpha","content":"<div>\n<p>Truist Securities has lowered its rating on Biomea Fusion (NASDAQ:BMEA) to hold, citing uncertainty about the timeline for resolving an FDA clinical hold on the company’s lead asset BMF-219. “We ...</p>\n\n<a href=\"https://seekingalpha.com/news/4114881-truist-cuts-biomea-fusion-to-hold-cites-clinical-hold-uncertainty\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Truist cuts Biomea Fusion to hold, cites clinical hold uncertainty</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTruist cuts Biomea Fusion to hold, cites clinical hold uncertainty\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-11 22:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4114881-truist-cuts-biomea-fusion-to-hold-cites-clinical-hold-uncertainty><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Truist Securities has lowered its rating on Biomea Fusion (NASDAQ:BMEA) to hold, citing uncertainty about the timeline for resolving an FDA clinical hold on the company’s lead asset BMF-219. “We ...</p>\n\n<a href=\"https://seekingalpha.com/news/4114881-truist-cuts-biomea-fusion-to-hold-cites-clinical-hold-uncertainty\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BMEA","symbol_name":"Biomea Fusion, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4114881-truist-cuts-biomea-fusion-to-hold-cites-clinical-hold-uncertainty","article_id":"2442031363","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1384646810/image_1384646810.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2442031363","pubTimestamp":1718117574,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Truist Securities has lowered its rating on Biomea Fusion  to hold, citing uncertainty about the timeline for resolving an FDA clinical hold on the company’s lead asset BMF-219. “We expect the stock to trade in a band, following the pullback, until the hold is lifted and there is clarity on a path forward for the drug,” Truist said in its note. Truist also withdrew its price target on the stock, citing recent volatility in the shares and low share price.  “If the data in Q4 are positive and if the clinical hold is lifted, we see potential for the stock to appreciate,” it added.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BMEA":"Biomea Fusion, Inc.","BK4539":"次新股","BK4585":"ETF&股票定投概念","BK4139":"生物科技"},"translate_title":"Truist以临床持有不确定性为由将Biomea Fusion削减至持有","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMEA":1},"content_text":"Truist Securities has lowered its rating on Biomea Fusion (NASDAQ:BMEA) to hold, citing uncertainty about the timeline for resolving an FDA clinical hold on the company’s lead asset BMF-219. “We expect the stock to trade in a band, following the pullback, until the hold is lifted and there is clarity on a path forward for the drug,” Truist said in its note. Truist also withdrew its price target on the stock, citing recent volatility in the shares and low share price.  “If the data in Q4 are positive and if the clinical hold is lifted, we see potential for the stock to appreciate,” it added.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2442031363"}